← All indications
Hearing Loss, Sensorineural
Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.
Subtype terms (4)
More specific conditions that are subtypes of Hearing Loss, Sensorineural in the MeSH hierarchy.
- Hearing Loss, Central
- Hearing Loss, Noise-Induced
15 drugs (10 approved, 5 experimental)
- Presbycusis
3 drugs experimental
- Usher Syndromes
7 drugs (1 approved, 6 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (11)
Phase 2 trials (16)
Phase 1 trials (9)
Organizations
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (15)
- Nordmark Arzneimittel GmbH & Co. KG
- Otonomy, Inc.
- Advent Health
- Northwell Health
- University of Colorado, Denver
- Worldwide Clinical Trials
- LCR Clinical Research
- Ludwig Maximilians University
- ClinSupport GmbH
- MWI Medizinisches Wirtschaftsinstitut GmbH
- Cord Blood Registry, Inc.
- ProjectPharm s.r.o.
- X-act Cologne Clinical Research GmbH
- Frequency Therapeutics
- Pipeline Therapeutics, Inc.
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (3)